Ubonratchathani Cancer Hospital   Report issue

Academic/Hospital Phase 2 Phase 3
Founded: Ubon Ratchathani Thailand (2003)

Organization Overview

First Clinical Trial
2012
NCT01364675
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now

Alternative names

Ubon Ratchathani Cancer Hospital, Ubon Ratchathani | Ubon Ratchathani Public Health Office, Thailand

Active Ingredients

Drugs in Phase 3 Trials (3)

carboplatin (paraplatin) (1 trial)

cisplatin (platinol) (1 trial)

paclitaxel (taxol) (1 trial)

Drugs in Phase 2 Trials (1)

melatonin (1 trial)

Drugs in Other Trials (3)

enalapril (vasotec) (1 trial)

simvastatin (zocor) (1 trial)

sitagliptin (januvia) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Head and Neck Neoplasms (Phase 2)

Mucositis (Phase 2)

Stomatitis (Phase 2)

Uterine Cervical Neoplasms (Phase 3)

Xerostomia (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 3
  • # of Trial APIs: 7